INmune Bio publishes preclinical study on XPro1595 and brain injury

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to INmune Bio publishes preclinical study on XPro1595 and brain injury
(NASDAQ: INMB) Delayed: 2.53 +0.02 (0.80%)
Previous Close $2.51    52 Week High $ 
Open $2.55    52 Week Low $ 
Day High $2.58    P/E N/A 
Day Low $2.47    EPS $ 
Volume 118,249